80 related articles for article (PubMed ID: 9742920)
1. Commercialization of BRCA1/2 testing: practitioner awareness and use of a new genetic test.
Cho MK; Sankar P; Wolpe PR; Godmilow L
Am J Med Genet; 1999 Mar; 83(3):157-63. PubMed ID: 10096590
[TBL] [Abstract][Full Text] [Related]
2. Personalised Risk Prediction in Hereditary Breast and Ovarian Cancer: A Protocol for a Multi-Centre Randomised Controlled Trial.
Archer S; Fennell N; Colvin E; Laquindanum R; Mills M; Dennis R; Stutzin Donoso F; Gold R; Fan A; Downes K; Ford J; Antoniou AC; Kurian AW; Evans DG; Tischkowitz M
Cancers (Basel); 2022 May; 14(11):. PubMed ID: 35681696
[TBL] [Abstract][Full Text] [Related]
3. Making sense of breast cancer risk estimates.
O'Quigley J
Genet Epidemiol; 2024 Apr; 48(3):141-147. PubMed ID: 38334222
[TBL] [Abstract][Full Text] [Related]
4. Subjective and Objective Risks of Carrying a BRCA1/2 Mutation in Individuals of Ashkenazi Jewish Descent.
Kelly K; Leventhal H; Toppmeyer D; Much J; Dermody J; Marvin M; Baran J; Schwalb M
J Genet Couns; 2003 Aug; 12(4):351-71. PubMed ID: 26141175
[TBL] [Abstract][Full Text] [Related]
5. Successful use of peer educators for sharing genetic information.
Venne VL; Hamann HA
J Genet Couns; 2007 Aug; 16(4):515-25. PubMed ID: 17597387
[TBL] [Abstract][Full Text] [Related]
6. Breast cancer susceptibility genes. BRCA1 and BRCA2.
Brody LC; Biesecker BB
Medicine (Baltimore); 1998 May; 77(3):208-26. PubMed ID: 9653432
[TBL] [Abstract][Full Text] [Related]
7. Overestimation of hereditary breast cancer risk.
Iglehart JD; Miron A; Rimer BK; Winer EP; Berry D; Shildkraut MJ
Ann Surg; 1998 Sep; 228(3):375-84. PubMed ID: 9742920
[TBL] [Abstract][Full Text] [Related]
8. A high occurrence of BRCA1 and BRCA2 mutations among Czech hereditary breast and breast-ovarian cancer families.
Machácková E; Foretová L; Navrátilová M; Valík D; Claes K; Messiaen L
Cas Lek Cesk; 2000 Oct; 139(20):635-7. PubMed ID: 11192759
[TBL] [Abstract][Full Text] [Related]
9. BRCA1, BRCA2, and hereditary nonpolyposis colorectal cancer gene mutations in an unselected ovarian cancer population: relationship to family history and implications for genetic testing.
Rubin SC; Blackwood MA; Bandera C; Behbakht K; Benjamin I; Rebbeck TR; Boyd J
Am J Obstet Gynecol; 1998 Apr; 178(4):670-7. PubMed ID: 9579428
[TBL] [Abstract][Full Text] [Related]
10. Histology of prophylactically removed ovaries from BRCA1 and BRCA2 mutation carriers compared with noncarriers in hereditary breast ovarian cancer syndrome kindreds.
Casey MJ; Bewtra C; Hoehne LL; Tatpati AD; Lynch HT; Watson P
Gynecol Oncol; 2000 Sep; 78(3 Pt 1):278-87. PubMed ID: 10985881
[TBL] [Abstract][Full Text] [Related]
11. Testing for hereditary breast and ovarian cancer in the southeastern United States.
Miron A; Schildkraut JM; Rimer BK; Winer EP; Sugg Skinner C; Futreal PA; Culler D; Calingaert B; Clark S; Kelly Marcom P; Iglehart JD
Ann Surg; 2000 May; 231(5):624-34. PubMed ID: 10767783
[TBL] [Abstract][Full Text] [Related]
12. Frequency of BRCA1 and BRCA2 mutations in a clinic-based series of breast and ovarian cancer families.
Vaziri SA; Krumroy LM; Rostai M; Casey G
Hum Mutat; 2001; 17(1):74. PubMed ID: 11139249
[TBL] [Abstract][Full Text] [Related]
13. Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2.
Parmigiani G; Berry D; Aguilar O
Am J Hum Genet; 1998 Jan; 62(1):145-58. PubMed ID: 9443863
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
